MK-677 (Ibutamoren): The Oral Growth Hormone Secretagogue — Complete Guide

What Is MK-677?

MK-677, also known as Ibutamoren, is a potent, orally active growth hormone secretagogue that mimics the action of ghrelin — the hunger hormone. By binding to ghrelin receptors (GHS-R1a) in the brain, MK-677 stimulates the pituitary gland to release growth hormone in a sustained, pulsatile pattern.

Unlike injectable growth hormone peptides like CJC-1295 or Ipamorelin, MK-677 is taken orally, making it one of the most convenient approaches to growth hormone optimization. A single daily dose can elevate GH and IGF-1 levels for up to 24 hours.

MK-677 is not a peptide — it is a non-peptidyl growth hormone secretagogue. It was developed by Merck in the 1990s and has been studied in clinical trials for muscle wasting, osteoporosis, and growth hormone deficiency. While never approved as a pharmaceutical, it is available through physician-supervised longevity protocols.

How MK-677 Works

MK-677 binds to ghrelin receptors in the hypothalamus and pituitary, triggering growth hormone release. The mechanism is similar to Ipamorelin but achieved through an oral route rather than injection. This makes MK-677 particularly attractive for patients who prefer not to inject.

Unlike exogenous HGH, MK-677 preserves the natural pulsatile pattern of GH release. It amplifies the body's own GH pulses, particularly the large nocturnal pulse during deep sleep. This is why MK-677 is typically taken before bed — it enhances both GH release and sleep architecture simultaneously.

MK-677 also increases IGF-1 levels over time. Studies show IGF-1 elevations of 40-89% after several weeks of daily dosing at 25mg. Importantly, MK-677 does not significantly increase cortisol or prolactin at standard doses, though it does increase appetite through its ghrelin-mimetic effects.

The appetite-stimulating effect is the most common side effect and can be significant. Some users report intense hunger, particularly in the first 2-4 weeks. This effect can be managed by taking MK-677 immediately before bed or by starting at a lower dose (10mg) and titrating up.

Benefits and Clinical Evidence

Sleep quality improvement is one of the most consistently reported benefits. MK-677 increases the duration of REM sleep and slow-wave (deep) sleep by up to 50% in some studies. A study in Neuroendocrinology showed significant improvements in sleep quality in young and elderly subjects at 25mg daily.

Body composition benefits include increased lean body mass and reduced fat mass. A 2-month study in the Journal of Clinical Endocrinology and Metabolism showed increased fat-free mass in elderly subjects at 25mg daily. These changes occur partly through GH-mediated lipolysis and protein synthesis.

Bone density improvements have been demonstrated in clinical trials. An 18-month study in the Journal of Clinical Endocrinology and Metabolism showed increased bone mineral density at the femoral neck in elderly women — a site highly relevant for osteoporotic fracture risk.

Nitrogen retention and wound healing benefits have been shown in studies of post-surgical patients and those with catabolic conditions. MK-677's ability to maintain positive nitrogen balance makes it useful during caloric deficit or recovery from injury.

Dosing and Safety Considerations

Typical MK-677 dosing is 10-25mg orally once daily, taken before bed. Most users start at 10mg for the first 1-2 weeks and increase to 25mg based on tolerance. The bedtime timing maximizes the sleep-enhancing and GH-releasing effects while minimizing daytime hunger.

Cycle length is debated. Some physicians recommend continuous use for 6-12 months with regular IGF-1 monitoring. Others prefer 12 weeks on, 4 weeks off. Long-term safety data from clinical trials up to 18 months supports continuous use at 25mg daily.

Important safety considerations include blood glucose monitoring. MK-677 can impair insulin sensitivity and raise fasting blood glucose, particularly in individuals predisposed to insulin resistance. HbA1c and fasting glucose should be monitored regularly. Diabetics and pre-diabetics should use MK-677 with extra caution.

MK-677 may also cause water retention and mild edema, particularly in the first few weeks. This typically resolves or becomes manageable over time. Monitoring blood pressure is recommended. Explore MK-677 and all 100 compounds in the Longevity AI Compound Wiki and Dose Calculator at longevityai.io.